219 related articles for article (PubMed ID: 11168640)
1. The identification of plant lectins with mucosal adjuvant activity.
Lavelle EC; Grant G; Pusztai A; Pfüller U; O'Hagan DT
Immunology; 2001 Jan; 102(1):77-86. PubMed ID: 11168640
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunogenicity of plant lectins in mice.
Lavelle EC; Grant G; Pusztai A; Pfüller U; O'Hagan DT
Immunology; 2000 Jan; 99(1):30-7. PubMed ID: 10651938
[TBL] [Abstract][Full Text] [Related]
3. Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2.
Lavelle EC; Grant G; Pusztai A; Pfüller U; Leavy O; McNeela E; Mills KH; O'Hagan DT
Immunology; 2002 Oct; 107(2):268-74. PubMed ID: 12383207
[TBL] [Abstract][Full Text] [Related]
4. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
[TBL] [Abstract][Full Text] [Related]
5. Immunoadjuvant and Humoral Immune Responses of Garlic (
Padiyappa SD; Avalappa H; Somegowda M; Sridhara S; Venkatesh YP; Prabhakar BT; Pramod SN; Almujaydil MS; Shokralla S; Abdelbacki AMM; Elansary HO; El-Sabrout AM; Mahmoud EA
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209158
[TBL] [Abstract][Full Text] [Related]
6. Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions.
Ekström J; Hu KF; Bengtsson KL; Morein B
Vaccine; 1999 Jun; 17(20-21):2690-701. PubMed ID: 10418920
[TBL] [Abstract][Full Text] [Related]
7. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
8. Nasally administered cholera toxin A-subunit acts as a mucosal adjuvant.
Campos EA; Namikoshi J; Maeba S; Yamamoto M; Fukumoto M; Yamamoto H
J Oral Sci; 2003 Mar; 45(1):25-31. PubMed ID: 12816361
[TBL] [Abstract][Full Text] [Related]
9. Immunological implications of the use of plant lectins for drug and vaccine targeting to the gastrointestinal tract.
Lavelle EC; Grant G; Pfuller U; O'Hagan DT
J Drug Target; 2004 Feb; 12(2):89-95. PubMed ID: 15203902
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of ovalbumin-specific IgA responses via oral boosting with antigen co-administered with an aqueous Solanum torvum extract.
Israf DA; Lajis NH; Somchit MN; Sulaiman MR
Life Sci; 2004 Jun; 75(4):397-406. PubMed ID: 15147827
[TBL] [Abstract][Full Text] [Related]
11. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice.
Huang CF; Wu TC; Chu YH; Hwang KS; Wang CC; Peng HJ
Scand J Immunol; 2008 Nov; 68(5):502-10. PubMed ID: 18822109
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunization with liposomes induces strong mucosal immune responses in mice.
Vadolas J; Davies JK; Wright PJ; Strugnell RA
Eur J Immunol; 1995 Apr; 25(4):969-75. PubMed ID: 7737300
[TBL] [Abstract][Full Text] [Related]
13. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine.
Abd Alla MD; White GL; Rogers TB; Cary ME; Carey DW; Ravdin JI
Infect Immun; 2007 Aug; 75(8):3812-22. PubMed ID: 17526742
[TBL] [Abstract][Full Text] [Related]
14. Application of phosphorylcholine derivative as mucosal adjuvant enhancing mucosal immune responses in the upper respiratory tract.
Jimura T; Kurono Y; Hirano T; Kawabata M; Yamashita M
Auris Nasus Larynx; 2024 Feb; 51(1):221-229. PubMed ID: 37532644
[TBL] [Abstract][Full Text] [Related]
15. Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage.
Externest D; Meckelein B; Schmidt MA; Frey A
Infect Immun; 2000 Jul; 68(7):3830-9. PubMed ID: 10858191
[TBL] [Abstract][Full Text] [Related]
16. The member of the cyclic di-nucleotide family bis-(3', 5')-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant.
Libanova R; Ebensen T; Schulze K; Bruhn D; Nörder M; Yevsa T; Morr M; Guzmán CA
Vaccine; 2010 Mar; 28(10):2249-2258. PubMed ID: 20060510
[TBL] [Abstract][Full Text] [Related]
17. The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action.
Grdic D; Smith R; Donachie A; Kjerrulf M; Hörnquist E; Mowat A; Lycke N
Eur J Immunol; 1999 Jun; 29(6):1774-84. PubMed ID: 10382739
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
19. Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens.
Marinaro M; Di Tommaso A; Uzzau S; Fasano A; De Magistris MT
Infect Immun; 1999 Mar; 67(3):1287-91. PubMed ID: 10024572
[TBL] [Abstract][Full Text] [Related]
20. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.
Bromander AK; Ekman L; Kopf M; Nedrud JG; Lycke NY
J Immunol; 1996 Jun; 156(11):4290-7. PubMed ID: 8666800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
